Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
INTRODUCTION:Soft tissue tumours have diagnostic and therapeutic challenge due to a wide variety of histomorphological patterns. Soft tissue sarcomas are relatively infrequent and constitute less than 1 % of all malignant neoplasms. Immunohistochemical evaluation of Ki-67 is a rapid prognostic tool to assess the cellular proliferation better than mitotic index. METHODS: A prospective study was conducted with a total of 100 cases of soft tissue tumors to analyze the frequency and histomorphology. Soft tissue sarcomas were graded by FNCLCC grading system and were subjected to Ki-67 evaluation. Spearman's Rho and Pearman's correlation coefcients were calculated to determine the correlation between the histologic grade and Ki-67 index. RESULTS: Soft tissue tumours constituted only about 1.3% of all neoplasms. Benign tumours (50%) outnumbered intermediate (11%) and malignant soft tissue tumours (39%). Soft tissue tumours were more common in males (52%) than females (48%) and frequently observed in the sixth decade. The sites of predilection were upper extremities for benign tumours and lower extremities for malignant tumours. Most common benign soft tissue tumour was Neurobroma (19%) followed by Schwannoma (14%). Undifferentiated pleomorphic sarcomas were the most common malignant soft tissue tumour (28%). In FNCLCC grading, most of the sarcomas were grade III (42%). Ki-67 index was low in grade I sarcomas, variable in grade II sarcomas and high in grade III sarcomas. Spearman's rho and Pearman's correlation R values were 0.77 and 0.75 respectively and p value is less than 0.05. CONCLUSION: There is positive correlation between the histologic grade and Ki-67 proliferative index in soft tissue sarcomas. Ki-67 index can be used as an independent prognostic factor to predict the risk of distant metastasis. Prospective evaluation of Ki-67 should be carried out in patients with soft tissue sarcomas for planning adjuvant treatment modalities
INTRODUCTION:Soft tissue tumours have diagnostic and therapeutic challenge due to a wide variety of histomorphological patterns. Soft tissue sarcomas are relatively infrequent and constitute less than 1 % of all malignant neoplasms. Immunohistochemical evaluation of Ki-67 is a rapid prognostic tool to assess the cellular proliferation better than mitotic index. METHODS: A prospective study was conducted with a total of 100 cases of soft tissue tumors to analyze the frequency and histomorphology. Soft tissue sarcomas were graded by FNCLCC grading system and were subjected to Ki-67 evaluation. Spearman's Rho and Pearman's correlation coefcients were calculated to determine the correlation between the histologic grade and Ki-67 index. RESULTS: Soft tissue tumours constituted only about 1.3% of all neoplasms. Benign tumours (50%) outnumbered intermediate (11%) and malignant soft tissue tumours (39%). Soft tissue tumours were more common in males (52%) than females (48%) and frequently observed in the sixth decade. The sites of predilection were upper extremities for benign tumours and lower extremities for malignant tumours. Most common benign soft tissue tumour was Neurobroma (19%) followed by Schwannoma (14%). Undifferentiated pleomorphic sarcomas were the most common malignant soft tissue tumour (28%). In FNCLCC grading, most of the sarcomas were grade III (42%). Ki-67 index was low in grade I sarcomas, variable in grade II sarcomas and high in grade III sarcomas. Spearman's rho and Pearman's correlation R values were 0.77 and 0.75 respectively and p value is less than 0.05. CONCLUSION: There is positive correlation between the histologic grade and Ki-67 proliferative index in soft tissue sarcomas. Ki-67 index can be used as an independent prognostic factor to predict the risk of distant metastasis. Prospective evaluation of Ki-67 should be carried out in patients with soft tissue sarcomas for planning adjuvant treatment modalities
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.